Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

9

Number of overlapping holdings

10.6%

% of SBIO's 89 holdings also in PSCH

12.9%

% of PSCH's 70 holdings also in SBIO

Overlap by Weight
Sector Drift (SBIO minus PSCH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in SBIO
Weight
in PSCH
Overlap
ALKERMES PLC 3.8% 2.8% 2.8%
VERICEL CORPORATION 2.4% 1.8% 1.8%
PROTAGONIST THERAPEUTICS, INC. 1.8% 1.4% 1.4%
ACADIA PHARMACEUTICALS INC 2.4% 1.3% 1.3%
XENCOR INC 1.2% 0.9% 0.9%

Position Highlights (Non-Overlapping Exposures)
SBIO Overweight Relative to PSCH
AXSOME THERAPEUTICS, INC. 3.2%
CRINETICS PHARMACEUTICALS INC 3.1%
AVIDITY BIOSCIENCES INC 2.9%
RHYTHM PHARMACEUTICALS, INC. 2.9%
PTC THERAPEUTICS INC 2.8%
MERUS N.V. 2.5%
MOONLAKE IMMUNOTHERAPEUTICS CLASS A 2.4%
ZAI LAB LTD. UNSPONSORED ADR 2.3%
DENALI THERAPEUTICS INC. 2.3%
AMICUS THERAPEUTICS INC 2.2%
SBIO Underweight Relative to PSCH
GLAUKOS CORP -5.4%
INSPIRE MEDICAL SYSTEMS, INC. -3.8%
MERIT MEDICAL SYSTEMS INC -3.5%
HIMS & HERS HEALTH, INC. CLASS A -3.0%
CORCEPT THERAPEUTICS INC -2.9%
INTEGER HOLDINGS CORPORATION -2.8%
RADNET INC -2.8%
ADMA BIOLOGICS, INC. -2.7%
ORGANON & CO. -2.5%
INARI MEDICAL, INC. -2.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY